Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs

Dow Jones – HealthFriday, October 17, 2025 at 10:23:00 AM
NegativeHealth
Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs
Novo Nordisk's shares have taken a hit following President Trump's announcement to negotiate lower prices for weight-loss drugs. This move is significant as it could lead to reduced costs for Americans, but it raises concerns about the financial impact on the pharmaceutical company and its investors.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk
PositiveHealth
The FDA has granted approval for Novo Nordisk's Rybelsus, the first oral GLP-1 medication, to be marketed for its heart risk reduction benefits in addition to its existing use for Type 2 diabetes. This is significant as it expands the drug's application, potentially improving the health outcomes for patients at risk of cardiovascular events, making it a valuable option in diabetes management.
Trump Rattles Vaccine Experts Over Aluminum
NegativeHealth
President Trump's recent suggestion to remove aluminum from childhood vaccines has raised significant concerns among vaccine experts. This proposal could impact about half of the vaccines for diseases like polio and whooping cough, which rely on aluminum to enhance immunity. Experts emphasize that aluminum has a proven safety record and is crucial for effective vaccination. This debate highlights the ongoing tension between public health recommendations and political discourse, making it essential for parents to stay informed about vaccine safety.
Democratic governors form a public health alliance in a rebuke of Trump
PositiveHealth
A coalition of Democratic governors has come together to form a public health alliance, aiming to enhance data sharing and communication regarding health threats and emergency preparedness. This initiative is particularly significant as it arises during a period when many feel the federal government is falling short in its public health responsibilities. By collaborating, these governors hope to ensure better health outcomes for their states and address pressing health issues more effectively.
Novo Nordisk to Buy Blood Disease Drug From Omeros for Up to $2.1 Billion
PositiveHealth
Novo Nordisk's recent agreement to acquire the blood disease drug zaltenibart from Omeros for up to $2.1 billion marks a significant step in expanding its portfolio. This deal not only highlights Novo Nordisk's commitment to addressing critical health issues but also positions them to potentially lead in the treatment of blood diseases. The exclusive global rights to develop and commercialize zaltenibart could pave the way for innovative therapies, benefiting patients and enhancing the company's market presence.
Latest from Health
A Furious Debate Over Autism’s Causes Leaves Parents Grasping for Answers
NegativeHealth
The ongoing debate over the causes of autism has left many parents feeling frustrated and confused. With conflicting research and opinions, families are struggling to find clear answers about what might contribute to autism. This matters because understanding the causes can help in early intervention and support for affected children, but the lack of consensus only adds to the anxiety of parents seeking clarity.
'An adult weekender at Butlin's saved my life'
PositiveHealth
Charlotte Monjaria's recent weekend getaway with friends at Butlin's turned into a life-saving experience when she discovered a cancerous tumor. This highlights the importance of taking time for ourselves and how unexpected moments can lead to critical health revelations. It's a reminder that self-care and social connections can have profound impacts on our well-being.
Exciting results from blood test for 50 cancers
PositiveHealth
The Galleri test has shown promising results in detecting 50 types of cancer by identifying DNA fragments from tumors in the bloodstream. This breakthrough could revolutionize early cancer detection, allowing for timely interventions and potentially saving lives. As more people get screened, the hope is to catch cancers earlier than ever before, making treatment more effective.
Woman's rare cancer found after Butlin's holiday injury
NeutralHealth
Charlotte enjoyed a wonderful weekend at Butlin's, but shortly after, she received a shocking diagnosis of a rare cancer. This news highlights the importance of regular health check-ups, as unexpected health issues can arise even after seemingly joyful experiences.
FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk
PositiveHealth
The FDA has granted approval for Novo Nordisk's Rybelsus, the first oral GLP-1 medication, to be marketed for its heart risk reduction benefits in addition to its existing use for Type 2 diabetes. This is significant as it expands the drug's application, potentially improving the health outcomes for patients at risk of cardiovascular events, making it a valuable option in diabetes management.
Three Cases of Mpox Tied to Severe Illness Worry Health Experts
NegativeHealth
Health experts are expressing concern over three cases of mpox in California that have resulted in severe illness, especially since none of the patients had traveled abroad, indicating local transmission of the Clade 1 variant. This situation raises alarms about the potential spread of the virus within communities and highlights the importance of vaccination efforts to prevent further outbreaks.